Pricing Log in Create free account

Cardiff Oncology, Inc. (CRDF) vs XBiotech Inc. (XBIT)

Cardiff Oncology, Inc. and XBiotech Inc. are both Biotechnology companies. Cardiff Oncology, Inc. and XBiotech Inc. are of similar size ($58.8M and $57.0M). Cardiff Oncology, Inc. grew revenue faster over the last twelve months: −6.79% against −78.2%. XBiotech Inc. has the higher net margin (0.00% vs −7,889.0%) and the lower return on invested capital (−159.2% vs 0.00%). Across the 16 metrics below, XBiotech Inc. leads on 10 and Cardiff Oncology, Inc. on 6.

Valuation

Metric CRDF XBIT Biotechnology median
P/E n/m n/m 10.60
P/S 105.02 14.29 9.40
P/B 2.01 0.45 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.90 0.66
EV/Sales 39.84 (10.46) 9.02
Earnings yield (76.92%) (78.72%) (32.88%)
Free cash flow yield (76.74%) (71.50%) (23.13%)

Profitability

Metric CRDF XBIT Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (8,320.08%) 0.00% 0.00%
Net margin (7,888.98%) 0.00% 0.00%
Free cash flow margin (8,059.45%) 0.00% 0.00%
Return on equity (94.14%) (29.94%) (51.96%)
Return on assets (70.89%) (28.90%) (46.06%)
Return on invested capital 0.00% (159.18%) 0.00%

Growth

Metric CRDF XBIT Biotechnology median
Revenue growth (TTM) (6.79%) (78.20%) 6.76%
EPS growth (last fiscal year) 27.37% (18.25%) 29.88%
Revenue growth, 5-year CAGR 10.13% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRDF XBIT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.30 33.15 4.97
Net debt to EBITDA 1.18 2.33 1.01

Dividend

Metric CRDF XBIT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRDF XBIT Biotechnology median
Market cap 58.76m 57.01m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack